Nasal spray of stem cell particles for stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a nasal spray made from stem cell particles can help people recover after an ischemic stroke. It is for adults who had a stroke within the last two weeks and did not receive clot-busting treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke (a blocked blood vessel in the brain) within the last 2 weeks.
- You are between 18 and 70 years old.
- You did not receive clot-busting medicine or a procedure to remove the clot.
- Your stroke is in the front part of the brain (anterior circulation).
- You have no major bleeding in the brain, liver, kidney, or heart problems.
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of stem cell (from umbilical cord) can help people recover after a recent ischemic stroke. It aims to see if this treatment can improve movement and reduce disability.
This trial tests whether a patient's own bone marrow stem cells, given through a vein, can help improve recovery after a stroke. It is for people who had a moderate stroke 3 to 12 months ago and still have some disability.
This trial tests a new treatment called NouvSoma001 for people who have had an ischemic stroke within the last week. It aims to see if the treatment is safe and helps improve muscle strength and overall recovery.
This study tests whether a therapy made from stem cell secretions can help improve memory and thinking after an ischemic stroke. It is for people who had a clot-related stroke in the past 3 months and now have mild to moderate cognitive issues.
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
This trial tests whether a single infusion of cells from umbilical cord blood (stem cells) can help people recover from a recent moderate-to-severe stroke. It aims to see if this treatment is safe and could improve recovery when given within the first two days after a stroke.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.